WO2004099248A3 - Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr2 (agtr2) - Google Patents
Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr2 (agtr2) Download PDFInfo
- Publication number
- WO2004099248A3 WO2004099248A3 PCT/EP2004/004276 EP2004004276W WO2004099248A3 WO 2004099248 A3 WO2004099248 A3 WO 2004099248A3 EP 2004004276 W EP2004004276 W EP 2004004276W WO 2004099248 A3 WO2004099248 A3 WO 2004099248A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- agtr2
- disorders
- diseases
- therapeutics
- diagnostics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03010092 | 2003-05-05 | ||
EP03010092.9 | 2003-05-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004099248A2 WO2004099248A2 (en) | 2004-11-18 |
WO2004099248A3 true WO2004099248A3 (en) | 2005-01-20 |
Family
ID=33427033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/004276 WO2004099248A2 (en) | 2003-05-05 | 2004-04-22 | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr2 (agtr2) |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2004099248A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2425567T3 (en) | 2004-12-24 | 2013-10-16 | Spinifex Pharmaceuticals Pty Ltd | Method of treatment or prophylaxis |
US20130131007A1 (en) | 2005-09-07 | 2013-05-23 | Bebaas, Inc. | Vitamin b12 compositions |
EP2952185A1 (en) | 2006-03-20 | 2015-12-09 | Spinifex Pharmaceuticals Pty Ltd | Method of treatment or prophylaxis of inflammatory pain |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002063045A1 (en) * | 2001-02-02 | 2002-08-15 | Genaissance Pharmaceuticals, Inc. | Drug target isogenes: polymorphisms in the angiotensin receptor 2 gene |
WO2002087503A2 (en) * | 2001-04-26 | 2002-11-07 | Vanderbilt University | Compositions and methods for treating colorectal polyps and cancer |
-
2004
- 2004-04-22 WO PCT/EP2004/004276 patent/WO2004099248A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002063045A1 (en) * | 2001-02-02 | 2002-08-15 | Genaissance Pharmaceuticals, Inc. | Drug target isogenes: polymorphisms in the angiotensin receptor 2 gene |
WO2002087503A2 (en) * | 2001-04-26 | 2002-11-07 | Vanderbilt University | Compositions and methods for treating colorectal polyps and cancer |
Also Published As
Publication number | Publication date |
---|---|
WO2004099248A2 (en) | 2004-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005093092A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 44 (gpr44) | |
WO2004097421A3 (en) | Diagnostics and therapeutics for diseases associated with calcitonin receptor-like receptor (calcrl) | |
WO2005095973A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 54 (gpr54) | |
WO2005106491A3 (en) | Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1) | |
WO2004080373A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2) | |
WO2005050225A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 84 (gpr84) | |
WO2004099782A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39) | |
WO2005093091A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 26 (gpr26) | |
WO2004082568A3 (en) | Diagnostics and therapeutics for diseases associated with complement component 5a receptor (c5ar) | |
WO2004099248A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr2 (agtr2) | |
WO2005040211A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 1 (gpr1) | |
WO2005040825A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 20 (gpr20) | |
WO2005059546A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35) | |
WO2005108998A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor beta-3 adreno (adrb3) | |
WO2004099783A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4) | |
WO2004082571A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 86 (gpr86) | |
WO2004081563A3 (en) | Diagnostics and therapeutics for diseases associated with phosphodiesterase 1a (pde1a) | |
WO2004080374A3 (en) | Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c) | |
WO2005040824A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 24 (gpr24) | |
WO2005040790A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 75 (gpr75) | |
WO2004097422A3 (en) | Diagnostics and therapeutics for diseases associated with calcitonin receptor (calcr) | |
WO2005059561A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 31 (gpr31) | |
WO2005040822A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 25 (gpr25) | |
WO2005114209A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-dependent receptor kinase 2 (grk2) | |
WO2004099781A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor rdc1 (rdc1) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |